Estuary Biotherapeutics (Seed and Series A)
Funding Details
Awarder
Inbox
Date Award
October 19, 2026
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount
$103,000,000
Company Info
Founders
Wayne Sackett
Market
Genetic medicines for kidney diseases
Location
Menlo Park, CA, USA
Coinvestors
4BIO Capital, Biogen New Ventures, Deep Track Capital, GV, National Kidney Foundation, Pivotal bioVenture Partners, RA Capital Management, UPMC Enterprise
Company Description

Estuary is a biotechnology company developing genetic medicines for patients with serious kidney diseases.

Links
Website
Back to HomeBack to Biotechnology DealsView Funding Announcement